White matter abnormalities of the brain: similar to multiple sclerosis in adolescence
DOI:
https://doi.org/10.33448/rsd-v10i5.15231Keywords:
Brain injury; White matter; Neuromyelitis Optica; Adolescent.Abstract
Also known as Devic's disease, neuromyelitis optica (NMO) is an autoimmune inflammatory disease that affects the central nervous system, considerably similar to multiple sclerosis (MS). This study aimed to compare the similarities of the clinical feature presented with similar cases found in the medical literature, addressing the symptoms, diagnosis, and treatment. This is a descriptive, retrospective, and qualitative study, done through the technique of direct observation. An adolescent male patient came to our service complaining of weakness in the lower limbs and urinary retention and, subsequently, urinary incontinence, during hospitalization. After undergoing magnetic resonance imaging of the skull, a large lesion with a demyelinating characteristic was evident through the T2 and FLAIR sequences, hyperintense in the white matter of the right cerebral hemisphere, with the exuberant enhancement of the contrasted image. Subsequently, he presented weakness in the left dimidium of the body, with progressive worsening in some days, with the impossibility of walking. The treatment was initiated with pulse therapy of methylprednisolone and interferon beta, obtaining an excellent clinical control of the disease. Thus, diagnostic confirmation was only possible thanks to the identification of a single brain white matter lesion through imaging and serological examination, which constituted a tool of great importance for the differential diagnosis that made it possible to exclude multiple sclerosis and allowed the establishment of timely treatment for neuromyelitis optica.
References
Aragão, J., Tavares, M. et al. (2009). Como Preparar Um Relato De Caso Clínico. Cadernos UniFOA. Volta Redonda, ano IV, n. 9.
Breitkopf, K., Aytulun, A., Förster, M., et al. (2020). Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis. Front. Neurol. 11:782.
Cañellas, A. R., Gols, A. R., Izquierdo, J. R., et al. (2007). Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology; 48:393-409.
Chitnis, T., Glanz, B., Jaffin, S., Healy, B. (2009). Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler. 15:627-31.
Datar, R., Prasad, A. N., Tay, K. Y., Rupar, C. A., Ohorodnyk, P., Miller, M., Prasad, C. (2018). Magnetic resonance imaging in the diagnosis of white matter signal abnormalities. Neuroradiol J. 31(4):362-371.
Dos Passos, G. R. et al. (2018). MOG-IgG-associated optic neuritis, encephalitis and myelitis: lessons learned from neuromyelitis optica spectrum disorder. Front Neurol. 9: 217.
Eshaghi, A., Young, A. L., Wijeratne, P. A., Prados, F. et al. (2021). Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data. Nature Communications. 12(1):2078.
Filippi, M. et al. (2019). Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 18, 198–210.
Fletcher, R. H., Fletcher, S. W., Wagner, E. H. (2003). Epidemiologia clínica: elementos essenciais. 3rd ed. Porto Alegre: Artmed.
Fragoso, Y. D., Brooks, J. B. B., Leal, T. M. S. (2012). Perfil descritivo de esclerose múltipla com início até os 16 anos nos pacientes de um centro de referência do estado de São Paulo. Rev. Paul. Pediatr. 30(4 ):617-20.
Guzmán-De-Villoria, J. A., et al. (2010). Differential diagnosis of T2 hyperintense brainstem lesions: Part 1. Focal lesions. Semin Ultrasound CT MR. 31(3):246-59.
Hauser, S. L. et al. (2017). Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N. Engl. J. Med. 376, 221–234.
Jacob, A., McKeon, A., Nakashima, I. et al. (2013). Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. Journal of neurology, neurosurgery, and psychiatry, 84:922–30.
Jeong, I. H., Kim, S. H., Hyun, J. W., Joung, A., Cho, H. J., Kim, H. J. (2015). Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations. J Neurol Sci. 358: 118-124.
Kansara T. (2017). Neuromyelitis Optica. International Journal of Current Advanced Research, 06(04):3559-3561.
Lassmann, H. (2007). Multiple sclerosis: is there neurodegeneration independent from inflammation? Journal of the Neurological Science. 259:3-6.
Lindemer, E. R., Greve, D. N., Fischl, B., Salat, D. H., Gomez-Isla, T. (2018). White matter abnormalities ang cognition in patients with conflicting diagnoses and CSF profiles. Neurology. 24;90(17):e1461-e1469.
Mars, R. B, O’Muircheartaigh, J., Folloni, D., Li, L., Glasser, M. F., Jbabdi, S., et al. (2018). Concurrent analysis of white matter bundles and grey matter networks in the chimpanzee. Brain Struct Funct. 1-13.
Medana, I. M., Esiri, M. M. (2003). Axonal damage: a key predictor of outcome in human CNS diseases. Brain. 26:515-530.
Minguetti, G. Ressonância magnética na esclerose múltipla: análise de 270 casos. (2001). Arq. Neuro-Psiquiatr. 59(3A):563-569.
Offenbacher, H., Fazekas, F., Schmidt, R., et al. (1993). Assesment of MRI criteria for diagnosis of MS. Neurology. 43:905-909.
Pandit, L., Asgari, N., Apiwattanakul, M., et al. (2015). Demographic and clinical features of neuromyelitis optica: a review. Mult Scler. 21:845–853.
Paty, D. W., Oger, J. J. F., Kastrukoff, L. F., et al. (1988). MRI in the diagnosis of multiple sclerosis: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology. 38:180-185.
Renard, D., et al. (2015). Cortical abnormalities on MRI: what a neurologist should know. Pract Neurol. 15:257–265.
Schilling, K., Gao, Y., Janve, V., Stepniewska, I., Landman, B. A., Anderson, A. W. (2018). Confirmation of a gyral bias in diffusion MRI fiber tractography. Hum Brain Mapp. 39: 1449–1466.
Tenembaum, S., Chitnis, T., Nakashima, I. et al. (2016). Neuromyelitis optica spectrum disorders in children and adolescents. Neurology. 30;87(9 Suppl 2):S59-66.
Thompson, A. J., Baranzini, S. E., Geurts, J., Hemmer, B. & Ciccarelli, O. (2018). Multiple sclerosis. Lancet. 391, 1622–1636.
Verhey, L. H., Branson, H. M., Shroff, M. M., et al. (2011). MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: A prospective national cohort study. Lancet Neurol. 10(12):1065-1073.
Vigdorovich, N., Ben-Sira, L., Blumkin, L., Precel, R., Nezer, I., Yosovich, K., Cross, Z., Vanderver, A., Lev, D., Lerman-Sagie, T., Zerem, A. (2020). Brain White matter abnormalities associated with copy number of variants. Am J Med Genet A. 182(1):93-103.
Wingerchuk, D. M., Lucchinetti, C. F. (2007). Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Current Opinion in Neurology. 20:343-350.
Wingerchuk, D. M., et al (2015). International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 14; 85(2): 177–189.
Wolinsky, J. S. et al. (2018). Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial. Ann. Neurol. 84, 527–536.
Young, A. L. et al. (2018). Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat. Commun. 9, 4273.
Yin, R. K. (2005). Estudo de caso: planejamento e métodos. 3. ed. Porto Alegre, RS: Bookman, 212p.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Dilceu Silveira Tolentino Júnior; Sandra Neres Santos; Aquiles Castro Araújo; Arlanjo Bispo de Sousa Marques; Kleise Pinheiro Farias; André Barbosa Souza ; Roberto Carlos de Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
